TNR | T Williams/CQ-Roll Call/Getty
In my 15 years as a pharmaceutical physician, I oversaw over 200 clinical trials in oncology and supported regulatory approvals by global health authorities of 10 novel oncology treatments. I can confidently say: I know what “gold-standard science” looks like. And I know what it doesn’t look like. It doesn’t look like the science endorsed by Jayanta Bhattacharya (above) and Marty Makary, nominated respectively to head the National Institutes of Health and the Food and Drug Administration.
